Clincosm LogoSign in Get a demo

recurrent thyroid gland carcinoma

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Solid Tumor, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Ectomesenchymoma Trial in Puerto Rico, United States

Recruiting
  • Malignant Solid Neoplasm
  • +40 more
  • Biospecimen Collection
  • +6 more
  • Birmingham, Alabama
  • +172 more
Jan 27, 2023

Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston

Recruiting
  • Malignant Thyroid Gland Neoplasm
  • +6 more
  • Quality-of-Life Assessment
  • +3 more
  • Ann Arbor, Michigan
  • +1 more
Jan 24, 2023

Benign Thyroid Gland Tumor, Recurrent Thyroid Gland Carcinoma, Thyroid Gland Follicular Tumor of Uncertain Malignant Potential

Recruiting
  • Benign Thyroid Gland Neoplasm
  • +4 more
  • Quality-of-Life Assessment
  • Radiofrequency Ablation
  • Houston, Texas
    M D Anderson Cancer Center
Sep 3, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +38 more
  • Bevacizumab
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Recurrent Thyroid Gland Carcinoma, Stage III Differentiated Thyroid Gland Carcinoma AJCC v7, Stage III Thyroid Gland Medullary

Completed
Has Results
  • Recurrent Thyroid Gland Carcinoma
  • +12 more
  • Laboratory Biomarker Analysis
  • Pazopanib Hydrochloride
  • Scottsdale, Arizona
  • +21 more
Feb 4, 2020

Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma, Stage I Thyroid Gland Follicular Carcinoma

Completed
Has Results
  • Poorly Differentiated Thyroid Gland Carcinoma
  • +15 more
  • Cabozantinib S-malate
  • Laboratory Biomarker Analysis
  • Washington, District of Columbia
  • +6 more
Mar 7, 2018

Recurrent Thyroid Gland Carcinoma, Stage III Thyroid Gland Follicular Carcinoma, Stage III Thyroid Gland Papillary Carcinoma

Completed
Has Results
  • Recurrent Thyroid Gland Carcinoma
  • +4 more
  • Fludeoxyglucose F-18
  • +4 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jan 24, 2017

Recurrent Thyroid Gland Carcinoma, Stage I Thyroid Gland Papillary Carcinoma, Stage II Thyroid Gland Papillary Carcinoma Trial

Completed
Has Results
  • Recurrent Thyroid Gland Carcinoma
  • +4 more
  • Tampa, Florida
  • +5 more
Dec 2, 2016